BNP Paribas Financial Markets’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278M Sell
9,904,502
-6,624,160
-40% -$176M 0.14% 142
2025
Q4
$412M Buy
16,528,662
+6,867,850
+71% +$173M 0.19% 93
2025
Q3
$246M Sell
9,660,812
-11,413,258
-54% -$282M 0.13% 137
2025
Q2
$511M Sell
21,074,070
-4,082,069
-16% -$95.2M 0.29% 55
2025
Q1
$637M Buy
25,156,139
+6,225,148
+33% +$163M 0.37% 45
2024
Q4
$502M Sell
18,930,991
-7,221,865
-28% -$196M 0.28% 58
2024
Q3
$757M Buy
26,152,856
+14,557,032
+126% +$425M 0.51% 27
2024
Q2
$324M Sell
11,595,824
-1,863,313
-14% -$51.3M 0.26% 78
2024
Q1
$373M Buy
13,459,137
+3,271,594
+32% +$90.8M 0.33% 61
2023
Q4
$293M Sell
10,187,543
-607,890
-6% -$18.4M 0.33% 52
2023
Q3
$358M Buy
10,795,433
+1,046,134
+11% +$37M 0.46% 26
2023
Q2
$358M Buy
9,749,299
+5,547,555
+132% +$216M 0.45% 31
2023
Q1
$171M Buy
4,201,744
+660,528
+19% +$28.5M 0.24% 89
2022
Q4
$181M Buy
3,541,216
+692,252
+24% +$33.2M 0.28% 72
2022
Q3
$125M Sell
2,848,964
-1,070,705
-27% -$52M 0.2% 91
2022
Q2
$206M Buy
3,919,669
+1,284,447
+49% +$65.5M 0.32% 55
2022
Q1
$136M Sell
2,635,222
-1,231,486
-32% -$63.9M 0.18% 108
2021
Q4
$228M Sell
3,866,708
-503,992
-12% -$25M 0.33% 52
2021
Q3
$188M Sell
4,370,700
-456,258
-9% -$20.2M 0.27% 76
2021
Q2
$189M Buy
4,826,958
+1,086,466
+29% +$42.3M 0.25% 87
2021
Q1
$136M Buy
3,740,492
+1,126,720
+43% +$40M 0.2% 104
2020
Q4
$96.2M Sell
2,613,772
-2,718,407
-51% -$99.7M 0.18% 106
2020
Q3
$186M Buy
5,332,179
+344,457
+7% +$12.1M 0.27% 71
2020
Q2
$155M Buy
4,987,722
+2,591,122
+108% +$88M 0.27% 71
2020
Q1
$74.2M Sell
2,396,600
-3,371,994
-58% -$115M 0.15% 131
2019
Q4
$214M Sell
5,768,594
-472,099
-8% -$16.8M 0.39% 36
2019
Q3
$213M Buy
6,240,693
+1,390,669
+29% +$50.6M 0.38% 53
2019
Q2
$199M Buy
4,850,024
+551,887
+13% +$21.9M 0.4% 37
2019
Q1
$173M Sell
4,298,137
-538,973
-11% -$21.6M 0.37% 45
2018
Q4
$200M Sell
4,837,110
-1,620,307
-25% -$67.3M 0.47% 30
2018
Q3
$270M Sell
6,457,417
-370,583
-5% -$14.3M 0.4% 36
2018
Q2
$235M Buy
6,828,000
+1,580,634
+30% +$54M 0.39% 40
2018
Q1
$177M Sell
5,247,366
-507,107
-9% -$17.4M 0.33% 51
2017
Q4
$198M Sell
5,754,473
-3,605,975
-39% -$123M 0.35% 46
2017
Q3
$317M Buy
9,360,448
+854,289
+10% +$27.5M 0.77% 16
2017
Q2
$271M Buy
8,506,159
+2,412,276
+40% +$76.1M 0.82% 13
2017
Q1
$198M Buy
6,093,883
+1,211,903
+25% +$38.2M 0.52% 33
2016
Q4
$150M Buy
4,881,980
+3,247,511
+199% +$99.1M 0.7% 22
2016
Q3
$52.5M Buy
1,634,469
+277,623
+20% +$9.28M 0.22% 87
2016
Q2
$45.3M Sell
1,356,846
-1,064,403
-44% -$34M 0.2% 76
2016
Q1
$68.1M Sell
2,421,249
-3,641,036
-60% -$104M 0.29% 66
2015
Q4
$186M Buy
6,062,285
+922,919
+18% +$29M 0.45% 43
2015
Q3
$153M Buy
5,139,366
+3,516,701
+217% +$113M 0.38% 35
2015
Q2
$51.6M Sell
1,622,665
-4,449,808
-73% -$145M 0.14% 91
2015
Q1
$200M Buy
6,072,473
+635,659
+12% +$20.2M 0.55% 31
2014
Q4
$161M Sell
5,436,814
-1,201,568
-18% -$34.5M 0.57% 29
2014
Q3
$186M Buy
6,638,382
+1,794,512
+37% +$50.4M 0.16% 91
2014
Q2
$136M Sell
4,843,870
-1,545,657
-24% -$44.1M 0.13% 92
2014
Q1
$190M Buy
6,389,527
+1,581,991
+33% +$47.2M 0.15% 87
2013
Q4
$140M Sell
4,807,536
-4,218,994
-47% -$123M 0.1% 113
2013
Q3
$246M Buy
9,026,530
+4,208,675
+87% +$115M 0.18% 90
2013
Q2
$128M Buy
+4,817,855
New +$133M 0.09% 107

Other funds holding PFE

BNP Paribas Financial Markets's PFE Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Pfizer (PFE) stake by 40% in Q1 2026, selling an estimated $176M and leaving 9,904,502 shares worth $278M. The position accounts for 0.14% of the portfolio, ranked #142.

BNP Paribas Financial Markets first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $757M in Q3 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • BNP Paribas Financial Markets held 9,904,502 shares of Pfizer worth $278M as of Q1 2026.
  • BNP Paribas Financial Markets sold 6,624,160 Pfizer shares in Q1 2026, an estimated $176M.
  • Pfizer made up 0.14% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #142 holding.
  • BNP Paribas Financial Markets first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Financial Markets's Pfizer position peaked at $757M in Q3 2024.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.